Cite
Fujino T, Aoyagi Y, Takahashi M, et al. Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy. World J Gastrointest Pharmacol Ther. 2013;4(3):54-60doi: 10.4292/wjgpt.v4.i3.54.
Fujino, T., Aoyagi, Y., Takahashi, M., Yada, R., Yamamoto, N., Ohishi, Y., Nishiura, A., Kohjima, M., Yoshimoto, T., Fukuizumi, K., Nakashima, M., Kato, M., Kotoh, K., Nakamuta, M., & Enjoji, M. (2013). Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy. World journal of gastrointestinal pharmacology and therapeutics, 4(3), 54-60. https://doi.org/10.4292/wjgpt.v4.i3.54
Fujino, Tatsuya, et al. "Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy." World journal of gastrointestinal pharmacology and therapeutics vol. 4,3 (2013): 54-60. doi: https://doi.org/10.4292/wjgpt.v4.i3.54
Fujino T, Aoyagi Y, Takahashi M, Yada R, Yamamoto N, Ohishi Y, Nishiura A, Kohjima M, Yoshimoto T, Fukuizumi K, Nakashima M, Kato M, Kotoh K, Nakamuta M, Enjoji M. Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy. World J Gastrointest Pharmacol Ther. 2013 Aug 06;4(3):54-60. doi: 10.4292/wjgpt.v4.i3.54. PMID: 23919217; PMCID: PMC3729868.
Copy
Download .nbib